Results 11 to 20 of about 27,203 (237)

Plasmapheresis for Facilitating Readministration of Rituximab After Paradoxical Exacerbation in Pemphigus Vulgaris: A Case Report [PDF]

Clinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT Rare reports of post‐rituximab exacerbation of pemphigus vulgaris (PV) have been published, with some therapeutic protocols proposed for managing this condition. A 40‐year‐old female with PV experienced an exacerbation of mucocutaneous lesions following rituximab administration.
Mohammad Reza Pourani, Sayyed Mojtaba Nekooghadam, Fatemeh Samadi, Sanaz Soleimani, Fahimeh Abdollahimajd   +4 more
wiley   +2 more sources

Association of regular plasmapheresis donation with serum protein and electrolyte levels: a multicentre cross-sectional study in China [PDF]

BMJ Open
Background China’s plasmapheresis donation policy differs from that of Western countries. The association between regular plasmapheresis donation and donor health in China is still unknown.Objectives To investigate the association of regular ...
Yu Zhang, Hui Yang, Ya Wang, Jun Zeng, Wan Li, Yongjun Chen, Guanglin Xiao, Changqing Li, Wenfu Song, Yating Yang, Zhongping Pu, Xiufang Wang, Shina Xie, Shouqiang Yang   +13 more
doaj   +2 more sources

Management and long-term outcome of recurrent idiopathic FSGS in pediatric kidney transplant recipients [PDF]

Scientific Reports
Focal segmental glomerulosclerosis (FSGS) is a major cause of pediatric kidney failure. Most cases of FSGS in children are idiopathic and have a high risk of post-transplantation recurrence and graft loss.
Moran Plonsky-Toder, Shirley Pollack, Rami Tibi, Irina Libinson-Zebegret, Renata Yaakobov, Israel Eisenstein, Daniella Magen   +6 more
doaj   +2 more sources

Plasmapheresis, immunosuppressive therapy and anti-GBM disease prognosis: a cohort study of 107 patients [PDF]

Renal Failure
Background Anti-glomerular basement membrane (anti-GBM) disease presents with rapidly progressive glomerulonephritis and alveolar hemorrhage, requiring urgent management.
Ying Liu, Yiting Wu, Wei Wei, Letian Yang, Caihong Liu, Jian Li, Yongxiu Huang, Bo Wang, Yingying Yang, Ling Zhang, Ping Fu, Yuliang Zhao   +11 more
doaj   +2 more sources

Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management

American Journal of Hematology, Volume 98, Issue 1, Page 193-209, January 2023., 2023
Abstract Disease Overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis Fungoides (MF) or Sézary Syndrome (SS). Diagnosis The diagnosis of MF or SS requires the integration of clinical and histopathologic data.
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox   +2 more
wiley   +1 more source

COVID‐19 and myasthenia gravis: A review of neurological implications of the SARS‐COV‐2

Brain and Behavior, Volume 12, Issue 12, December 2022., 2022
Abstract Introduction This review highlights the potential mechanisms of neuromuscular manifestation of COVID‐19, especially myasthenia gravis (MG). Methods An extensive literature search was conducted by two independent investigators using PubMed/MEDLINE and Google Scholar from its inception to December 2020. Results Exacerbations of clinical symptoms
Syed Muhammad Ismail Shah, Farah Yasmin, Roha Saeed Memon, Nadia Nazir Jatoi, Ilma Saleh Savul, Sana Kazmi, Syed Abdullah Monawwer, Muhammad Daim Bin Zafar, Muhammad Sohaib Asghar, Muhammad Junaid Tahir, Ka Yiu Lee   +10 more
wiley   +1 more source

Cryoglobulinemia and double‐filtration plasmapheresis: Personal experience and literature review

Therapeutic Apheresis and Dialysis, Volume 27, Issue 1, Page 159-169, February 2023., 2023
Abstract Background Cryoglobulinemia is defined as the presence of an abnormal immunoglobulin that may be responsible for vasculitis of small‐caliber vessels. Apheresis can be used in order to temporarily eliminate circulating cryoglobulins. The aim of this study was to assess the effectiveness of apheresis (double‐filtration plasmapheresis‐DFPP‐) in ...
Hamza Naciri Bennani, Augustin Twite Banza, Florian Terrec, Johan Noble, Thomas Jouve, Lionel Motte, Paolo Malvezzi, Lionel Rostaing   +7 more
wiley   +1 more source

Real‐world application of plasmapheresis for neurological disease: Results from the Japan‐Plasmapheresis Outcome and Practice Patterns Study

Therapeutic Apheresis and Dialysis, Volume 27, Issue 1, Page 123-135, February 2023., 2023
Abstract Introduction Plasmapheresis is a well‐recognized treatment for autoimmune neurological diseases in Japan. However, the practice varies depending on the facility, and the actual treatment conditions are unclear. Methods To clarify real‐world conditions, a prospective observational study was conducted on patients with neurological diseases who ...
Youwei Lin, Satoru Oji, Katsuichi Miyamoto, Tomoko Narita, Mana Kameyama, Hidenori Matsuo   +5 more
wiley   +1 more source

Six years of continuous mechanical circulatory support following chronic graft failure

Artificial Organs, Volume 47, Issue 1, Page 214-216, January 2023., 2023
Re‐transplantation is the preferred treatment for patients with chronic heart transplant failure. If re‐transplantation is not a viable option due to the patient's comorbidities, left ventricle assist device can be used as the destination treatment. An interdisciplinary approach with thorough follow‐up can help in the early detection and treatment of ...
Mohamed Ghoneim, Jan Knierim, Felix Hedwig, Stephan D. Kurz   +3 more
wiley   +1 more source

CAQ Corner: Basic concepts of transplant immunology

, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source